Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083 | EVP and Chief Risk Officer | February 25, 2021 | March 11, 2021 |
| Oscar Health, Inc.OSCR · Entity 3582 | EVP, Chief Insurance Officer | December 05, 2024 | December 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL GROUP, INC.
Report date February 25, 2021 · Filed March 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,004 |
Reported balance
After 2021-02-25 transaction · row 1
1 source rowRow 1 · 2021-02-25 · Purchase · Acquired 19 · Balance 64,004 F1: The reporting person's purchase of shares of AIG common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the reporting person's sale of 12,750 shares of AIG common stock at prices ranging from $38.6700 to $38.7001 per share on December 14, 2020. Because the purchase price paid by the reporting person as reported herein was greater than the sale prices of her transactions on December 14, 2020, the reporting person did not realize any profit in connection with the matching transactions. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 11,029 |
Reported balance
Holding disclosure · report date 2021-02-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,029 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person's purchase of shares of AIG common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the reporting person's sale of 12,750 shares of AIG common stock at prices ranging from $38.6700 to $38.7001 per share on December 14, 2020. Because the purchase price paid by the reporting person as reported herein was greater than the sale prices of her transactions on December 14, 2020, the reporting person did not realize any profit in connection with the matching transactions.
Oscar Health, Inc.
Report date December 05, 2024 · Filed December 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 430,216 |
Ending reported balance
After 2024-12-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-12-05 · Exercise / conversion · Acquired 31,250 · Balance 447,009 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2024-12-06 · Sale · Disposed 10,385 · Balance 436,624 F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Row 3 · 2024-12-06 · Sale · Disposed 6,408 · Balance 430,216 F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-12-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-12-05 · Exercise / conversion · Disposed 31,250 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. |
| Class A Common StockSEC Table I · non-derivative | IndirectAlessandrea C Quane 2024 GRAT | 76,857 |
Reported balance
Holding disclosure · report date 2024-12-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 76,857 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F5: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2024 Filed Dec 9, 2024 16:41 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 6,408 | $16.52 | $105,860.16 |
DisclosureSEC source: 0001562180-24-008249 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,216 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 16:41 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 10,385 | $15.93 | $165,433.05 |
DisclosureSEC source: 0001562180-24-008249 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,624 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 16:41 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008249 · primarydocument.xml · derivative · entry 5 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 16:41 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-008249 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 484 | $18.48 | $8,944.32 |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · nonDerivative · entry 5 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415,759 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 26,411 | $18.07 | $477,246.77 |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · nonDerivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,243 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 8,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · derivative · entry 9 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,872 Underlying: Class A Common Stock · 8,653 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F7 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 34,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · derivative · entry 8 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,417 Underlying: Class A Common Stock · 34,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. F6 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 7,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · derivative · entry 7 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,048 Underlying: Class A Common Stock · 7,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F5 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 8,653 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 34,379 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 7,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-008101 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 16:52 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 16,793 | $17.06 | $286,488.58 |
DisclosureSEC source: 0001562180-24-006742 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,607 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 to $17.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:52 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006742 · primarydocument.xml · derivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,250 Underlying: Class A Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 16:52 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-006742 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 31,616 | $17.85 | $564,345.60 |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 7 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,150 F3 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 38,740 | $17.46 | $676,400.40 |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 6 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,766 F3 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 77,181 | $17.99 | $1,388,486.19 |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 5 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,506 F3 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 8,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · derivative · entry 11 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,525 Underlying: Class A Common Stock · 8,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F9 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F9 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 34,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · derivative · entry 10 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,796 Underlying: Class A Common Stock · 34,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F8 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. F8 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · derivative · entry 9 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,063 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F7 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 8,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 224,503 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 517,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Issuer previously granted the Reporting Person an award of 224,503 restricted stock units that vested on September 1, 2024, following the Talent & Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 34,380 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:36 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-006658 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 16,793 | $19.58 | $328,806.94 |
DisclosureSEC source: 0001562180-24-004846 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,136 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.45 to $19.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004846 · primarydocument.xml · derivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Class A Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-004846 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 04, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 668 | $19.09 | $12,752.12 |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · nonDerivative · entry 5 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,679 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 25,550 | $19.46 | $497,203.00 |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · nonDerivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,347 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 8,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · derivative · entry 9 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,177 Underlying: Class A Common Stock · 8,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F7 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 34,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · derivative · entry 8 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,176 Underlying: Class A Common Stock · 34,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. F6 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · derivative · entry 7 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,079 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F5 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 8,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 34,379 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 18:07 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-004668 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 17:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantRestricted Stock Units · Derivative | 103,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002608 · primarydocument.xml · derivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,829 Underlying: Class A Common Stock · 103,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 16:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 13,233 | $14.12 | $186,849.96 |
DisclosureSEC source: 0001562180-24-002400 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,850 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 to $14.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 16:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002400 · primarydocument.xml · derivative · entry 4 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Class A Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 16:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-002400 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 15,928 | $15.88 | $252,936.64 |
DisclosureSEC source: 0001562180-24-002259 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,833 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 34,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002259 · primarydocument.xml · derivative · entry 6 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 412,555 Underlying: Class A Common Stock · 34,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. F5 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 7,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002259 · primarydocument.xml · derivative · entry 5 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,095 Underlying: Class A Common Stock · 7,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 34,380 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-002259 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 7,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-002259 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 16:21 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 55,000 | $18.02 | $991,100.00 |
DisclosureSEC source: 0001562180-24-001539 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,366 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 06, 2023 Filed Dec 7, 2023 16:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 16,793 | $8.16 | $137,030.88 |
DisclosureSEC source: 0001562180-23-008196 · primarydocument.xml · nonDerivative · entry 2 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,223 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.08 to $8.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 16:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-008196 · primarydocument.xml · derivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Class A Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 16:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-008196 · primarydocument.xml · nonDerivative · entry 1 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 16:22 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 22,246 | $8.34 | $185,531.64 |
DisclosureSEC source: 0001562180-23-008109 · primarydocument.xml · nonDerivative · entry 3 Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,766 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.